Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
CCR9 Biologics Sequence Review Report 2026: C-C chemokine receptor type 9 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCR9 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCRL2 Biologics Sequence Review Report 2026: C-C chemokine receptor-like 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCRL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCR4 Biologics Sequence Review Report 2026: C-C chemokine receptor type 4 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCR3 Biologics Sequence Review Report 2026: C-C chemokine receptor type 3 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCR5 Biologics Sequence Review Report 2026: C-C chemokine receptor type 5 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCR2 Biologics Sequence Review Report 2026: C-C chemokine receptor type 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCR10 Biologics Sequence Review Report 2026: C-C chemokine receptor type 10 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCR10 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF11A Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 11A Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TNFRSF11A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF25 Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 25 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TNFRSF25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF18 Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 18 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TNFRSF18 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF13C Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 13C Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TNFRSF13C protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TNFRSF12A Biologics Sequence Review Report 2026: Tumor necrosis factor receptor superfamily member 12A Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TNFRSF12A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
316
317
318
319
320
>>
1222
>